Literature DB >> 23414471

Lifestyle modification in colorectal cancer patients: an integrative oncology approach.

Syed H Jafri1, Glenn Mills.   

Abstract

Colorectal cancer (CRC) is predominantly a disease of economically developed countries, with many lifestyle-related risk factors proposed that contribute to a higher incidence. These risk factors include obesity, especially visceral fat, lack of physical activity, high consumption of red and processed meat, alcohol and a low intake of dietary fiber. Many population-based studies suggest that a combination of these lifestyle-related risk factors not only increases the incidence of CRC, but also contributes to an increased risk of CRC recurrence after the initial diagnosis. In this article we have reviewed various scientific studies that link lifestyle risk factors with CRC and we propose lifestyle modification as an adjunct intervention to surgery and chemotherapy in patients with early stage and locally advanced CRC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23414471     DOI: 10.2217/fon.12.184

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  8 in total

1.  Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.

Authors:  Clemens Giessen-Jung; Dorothea Nagel; Maria Glas; Fritz Spelsberg; Ulla Lau-Werner; Dominik Paul Modest; Christoph Schulz; Volker Heinemann; Dorit Di Gioia; Petra Stieber
Journal:  Tumour Biol       Date:  2015-05-08

2.  Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers.

Authors:  Yan Zhang; Aleksandra Nowicka; Travis N Solley; Caimiao Wei; Aaroh Parikh; Laurence Court; Jared K Burks; Michael Andreeff; Wendy A Woodward; Ali Dadbin; Mikhail G Kolonin; Karen H Lu; Ann H Klopp
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

3.  Peroxisome Proliferator-Activated Receptor Gamma in Obesity and Colorectal Cancer: the Role of Epigenetics.

Authors:  T K Motawi; O G Shaker; M F Ismail; N H Sayed
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

4.  The impact of complications on prolonged length of hospital stay after resection in colorectal cancer: A retrospective study of Taiwanese patients.

Authors:  Herng-Chia Chiu; Yi-Chieh Lin; Hui-Min Hsieh; Hsin-Pao Chen; Hui-Li Wang; Jaw-Yuan Wang
Journal:  J Int Med Res       Date:  2017-02-07       Impact factor: 1.671

5.  FKBP14 Promotes The Proliferation And Migration Of Colon Carcinoma Cells Through Targeting IL-6/STAT3 Signaling Pathway.

Authors:  Leilei Yang; Ruili Zhang; Jie Yang; Tienan Bi; Shenkang Zhou
Journal:  Onco Targets Ther       Date:  2019-11-01       Impact factor: 4.147

6.  Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells.

Authors:  Yi-Jing Tao; Yong-Ju Li; Wen Zheng; Juan-Juan Zhao; Meng-Meng Guo; Ya Zhou; Na-Lin Qin; Jing Zheng; Lin Xu
Journal:  Cancer Cell Int       Date:  2015-08-01       Impact factor: 5.722

7.  MicroRNA-103 promotes colorectal cancer by targeting tumor suppressor DICER and PTEN.

Authors:  Li Geng; Bing Sun; Bo Gao; Zheng Wang; Cheng Quan; Feng Wei; Xue-Dong Fang
Journal:  Int J Mol Sci       Date:  2014-05-13       Impact factor: 5.923

Review 8.  Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics.

Authors:  Chenbo Ding; Wendong Tang; Xiaobo Fan; Guoqiu Wu
Journal:  Onco Targets Ther       Date:  2018-08-13       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.